Literature DB >> 5421080

Lipoprotein lipid alterations with cholestyramine administration.

R J Jones, L Dobrilovic.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5421080

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


× No keyword cloud information.
  7 in total

Review 1.  Bilirubin in the Liver-Gut Signaling Axis.

Authors:  Abdul-Rizaq Hamoud; Lauren Weaver; David E Stec; Terry D Hinds
Journal:  Trends Endocrinol Metab       Date:  2018-02-03       Impact factor: 12.015

2.  Treatment of hyperlipoproteinaemia type II A with a new anion exchange resin secholex.

Authors:  A Gustafson; A Lanner
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

3.  Experience with simplified scheme of treatment of hyperlipidaemia.

Authors:  S Tabaqchali; A Chait; R Harrison; B Lewis
Journal:  Br Med J       Date:  1974-08-10

4.  Linkage between cholesterol 7alpha-hydroxylase and high plasma low-density lipoprotein cholesterol concentrations.

Authors:  J Wang; D J Freeman; S M Grundy; D M Levine; R Guerra; J C Cohen
Journal:  J Clin Invest       Date:  1998-03-15       Impact factor: 14.808

Review 5.  Antihyperlipidaemic agents. Drug interactions of clinical significance.

Authors:  J A Farmer; A M Gotto
Journal:  Drug Saf       Date:  1994-11       Impact factor: 5.606

6.  The effects of colestipol resin and of colestipol plus clofibrate on the turnover of plasma cholesterol in man.

Authors:  D S Goodman; R P Noble; R B Dell
Journal:  J Clin Invest       Date:  1973-10       Impact factor: 14.808

7.  Effects of acipimox and cholestyramine on serum lipoproteins, non-cholesterol sterols and cholesterol absorption and elimination.

Authors:  H Gylling; H Vanhanen; T A Miettinen
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.